John David Finley
CEO, CFO, Director at Palisade Bio Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Palisade Bio Inc., 3 years.
Palisade Bio Inc.
Director · CEO, CFO
Chief executive roles
Palisade Bio Inc.
· CEO, CFO, Director
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Palisade Bio Inc. | Open-market sale | −146,798 | $2.07 | $303,343 |
| Jul 7, 2026 | Palisade Bio Inc. | Option exercise | +133 | $0.70 | $93 |
| Jul 6, 2026 | Palisade Bio Inc. | Option exercise | +335,167 | — | — |
| Feb 12, 2026 | Palisade Bio Inc. | Open-market sale | −3,896 | $1.75 | $6,818 |
| Feb 11, 2026 | Palisade Bio Inc. | Option exercise | +13,333 | — | — |
| May 28, 2024 | Palisade Bio Inc. | Option exercise | +1,622 | — | — |
| May 28, 2024 | Palisade Bio Inc. | Shares withheld for tax | −467 | $4.76 | $2,223 |
| May 28, 2024 | Palisade Bio Inc. | Option exercise | +3,335 | — | — |
| May 28, 2024 | Palisade Bio Inc. | Shares withheld for tax | −959 | $4.76 | $4,565 |
| May 28, 2024 | Palisade Bio Inc. | Option exercise | +2,111 | — | — |
| May 28, 2024 | Palisade Bio Inc. | Shares withheld for tax | −607 | $4.76 | $2,889 |
| May 24, 2024 | Palisade Bio Inc. | Open-market purchase | +1,000 | $4.81 | $4,810 |
| May 20, 2024 | Palisade Bio Inc. | Grant or award | +666 | $4.97 | $3,310 |
| May 6, 2024 | Palisade Bio Inc. | Option exercise | +232 | — | — |
| May 6, 2024 | Palisade Bio Inc. | Shares withheld for tax | −67 | $8.46 | $567 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.